New Technology– category –
-
Europe’s Regulatory Frontier for Advanced Biologics: Real-World Evidence and Patient Voices Shape Cell and Gene Therapies
ResearchGate (論文) Global Overview A new ResearchGate paper explores Europe's progressive regulatory landscape for advanced cell and gene therapies, a class of complex, engineered biologics. It underscores the critical role of integrati... -
Top 10 Emerging Healthcare Technologies in 2026: CRISPR Gene Editing Established as Therapeutic Category, Regenerative Medicine Nearing Clinical Application
Slate USA Overview An article on 10 emerging healthcare technologies to watch in 2026 highlights that CRISPR gene editing is moving beyond the lab to become a bona fide therapeutic category. Additionally, regenerative medicine and stem c... -
Advances in Multiple Myeloma Treatment: CAR-T, Bispecific Antibodies, and Antibody-Drug Conjugates Evolving in Approved & Clinical Stages
Myeloma Crowd USA Overview An article summarizing the latest advancements in multiple myeloma treatment highlights the diversification of approved and investigational approaches, including CAR-T cell therapies, bispecific T-cell engagers... -
Regentis Biomaterials Secures $6.5M Private Placement to Accelerate Regenerative Tissue Repair Solutions
BioSpace (Press Release) イスラエル Overview Regentis Biomaterials, an innovator in regenerative medicine, has successfully closed a $6.5 million private placement, securing capital through the issuance of common shares and warrants. Thi... -
Cell-Free Advantage: Exosome-Biomaterial Platforms Offer Safer Treatment for Diabetic Skin Infections, But Clinical Translation Remains Complex
International Journal of Nanomedicine (論文) Global Overview A recent review explores exosome-biomaterial platforms as a promising, safer alternative to cell therapies for diabetic skin infections. These 'cell-free' approaches address sa... -
Prime Medicine’s Autologous Prime Editing Hematopoietic Stem Cell Therapy PM359 for p47phox-Deficient Chronic Granulomatous Disease Receives FDA RMAT Designation
BiopharmaWatch (Prime Medicine Press Release) USA Overview Prime Medicine announced its investigational autologous prime editing hematopoietic stem cell therapy, PM359, for the treatment of p47phox-deficient Chronic Granulomatous Disease... -
Engineered Exosomes Breach Blood-Brain Barrier, Unlocking New Vistas in Neuro-Oncology
MDPI (論文) Global Overview The blood-brain barrier (BBB) critically impedes drug delivery to the brain, posing a major challenge for treating central nervous system diseases, particularly brain tumors. Engineered exosomes are emerging a... -
CRISPR Medicine News Roundup: Sickle Cell CRISPR Drug Shows Potent Results in Young Children, Caribou’s Off-the-Shelf CAR-T Delivers Positive Phase 1 Data
CRISPR Medicine News USA Overview A CRISPR Medicine News summary article reports that the first approved CRISPR gene therapy for sickle cell disease demonstrated equally potent results in children as young as 5 years old. Additionally, C... -
Exosomes: Unlocking Nature’s Nanoparticles for Precision Medicine, Navigating Translational Hurdles
Frontiers (論文) Global Overview Exosome research is rapidly advancing, revealing substantial potential in drug delivery and regenerative medicine due to their inherent biocompatibility and targeting capabilities. However, clinical trans... -
Genomic Engineering Strategies and Alternative Cell Types in Allogeneic T-Cell Immunotherapy Platforms Enable Scalable Cancer Treatment
Academic Publication Global Overview Allogeneic T-cell therapy is emerging as a highly promising strategy in cancer immunotherapy due to its scalability and 'off-the-shelf' availability, overcoming logistical and manufacturing constraint...
